期刊文献+

基质金属蛋白酶抑制剂研究进展 被引量:6

暂未订购
导出
摘要 基质金属蛋白酶是近年来发现的抗炎、抗癌的新靶点 ,被认为与关节软骨的溶解和癌细胞的转移有关。其晶体结构及作用机理已被阐明。本文对近年来国外报道的基质金属蛋白酶抑制剂进行了综述 ,分别介绍了拟肽和非肽两大类共 11种抑制剂 。
出处 《国外医学(药学分册)》 2001年第1期17-22,共6页 Foreign Medical Sciences(Section of Pharmarcy)
  • 相关文献

参考文献25

  • 1[1]Johnson LL, Dyer R, Hupe DJ, et al. Matrix metalloproteinases[J]. Curr Opin Chem Biol, 1998, 2(4):466 -471.
  • 2[2]Babine RE, Bender SL. Molecular recognition of proteinligand complexes: applications to drug design[ J]. Chem Rev, 1997, 97(5): 1359 - 1472.
  • 3[3]Bottomley KM, Johnson WH, Walter DS. MMPs inhibitors in arthritis[J]. J Enzyme Inhib, 1998, 13(2) :79- 101.
  • 4[4]Suzuki D. Metalloproteinases in the pathogenesis of diabetic nephropathy[J]. Nephron, 1998, 80(2): 125 - 133.
  • 5[5]Wojtowicz-Praga SM, Dickson RB, Hawkins MJ, et al.Matrix metalloproteinase inhibitors[ J]. Invest New Drugs,1997, 15(1):61-75.
  • 6[6]Brown PD. MMPs inhibitors[J]. Breast Cancer Res Treat,1998, 52(1/3): 125 - 136.
  • 7[7]Dhanara JV, Ye QZ, Johnson LL, et al. Designing inhibitors of the metalloproteinase superfamily: comparative analysis of representative structures[J]. Drug Des Discov,1996, 13(3/4) :3- 14.
  • 8[8]Kiyama R, Tamura Y, Watanabe F, et al. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors[J]. J Med Chem, 1999, 42(10): 1723 - 1738.
  • 9[9]Meng Qi, Malinovskii V, Huang W, et al. Residue 2 of TIMP-1 is a major determinant of affinity and specificity for MMPs but effects of substitutions do not correlate with those of the corresponding P1' residue of substrate [ J]. J Biol Chem, 1999, 274(15):10184- 10189.
  • 10[10]Gomlis-Ruth FX, Maskos K, Betz M, et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin1 by TIMP-1[J]. Nature, 1997, 389(6646) :77 - 81.

同被引文献72

  • 1张丽,徐文方.基质金属蛋白酶抑制剂在抗肿瘤治疗中的研究现状[J].生命的化学,2005,25(1):39-40. 被引量:3
  • 2徐卫国,李华.对甲苯磺酸三氟乙酯的合成[J].有机氟工业,2006(1):11-13. 被引量:5
  • 3贺兴东 等.中药学[M].北京:学苑出版社,1998.417.
  • 4韩向阳.实用计划生育学[M].哈尔滨:黑龙江科技出版社,1998.60.
  • 5Sang QA.Computational sequence analysis of matrix metalloproteinases[J].J Protein Chem,1996,15(2):137-160.
  • 6Myers EN,Schramm VL,Beanes EL Jr.Management of inverted papilloma of the nose and paeanasal sinuses [J].Laryngoscope,1981,91:2071-2084.
  • 7Calcattera TL,Thompson JW,Paglia DE.Inverted papilloma of the nose and paeanasal sinuses[J].Laryngoscope,1980,87:35-46.
  • 8Lesperance MM,Escalmado RM.Squamous cell carcinoma arising in invented papilloma [J].Laryngoscope,1995,105:178-183.
  • 9Schonemark M,Mester B,Kempf HG,et al.Expression of matrix metalloproteinases and their inhibitors in human cholesteatoma of the middlecar[J].Am J Otol,1992,13:350-355.
  • 10Kugler A. Matrix metalloproteinases and their inhibitors[ J ]. Anticancer Res, 1999,19(2c) :1589 - 1592.

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部